Table 1.
Association between MEF2D expression and clinicopathologic features in TSCC patients
Clinicopathologic feature | No. of cases | MEF2D expression (N) | P value | |||
---|---|---|---|---|---|---|
| ||||||
- | + | ++ | +++ | |||
Age, years | 0.4344 | |||||
≥50 | 18 | 6 | 5 | 4 | 3 | |
<50 | 22 | 6 | 8 | 4 | 4 | |
Gender | 0.1372 | |||||
Male | 19 | 6 | 6 | 3 | 4 | |
Female | 21 | 6 | 7 | 5 | 3 | |
Differentiation | 0.002 | |||||
Well | 20 | 8 | 9 | 2 | 1 | |
Moderately | 20 | 4 | 4 | 6 | 6 | |
Lymphatic metastasis | 0.003 | |||||
Yes | 19 | 3 | 5 | 6 | 5 | |
No | 21 | 9 | 8 | 2 | 2 |